Tirzepatide trials produced even better results, with the SURMOUNT-1 trial showing 15-22.5 percent body weight reduction depending on dose
It connects you with licensed clinicians who independently decide whether to prescribe
Step 3: Monitor progress and enjoy steady improvements in weight loss and metabolic health
Whether you are dealing with rheumatoid arthritis (RA), psoriatic arthritis (PsA), lupus (SLE), Sjgrens disease (SD), or even osteoarthritis (OA), chronic inflammation keeps the immune system in a constant attack mode, leading to: Pain Swelling Stiffness Mobility problems Tissue and cartilage damage This chronic, ongoing inflammation not only makes joints hurt more, but it will worsen blood sugar control, fatigue, brain fog, and increase the risk of heart disease
Many are on one already
Tirzepatide targets two receptors (GLP-1 and GIP), which may produce stronger appetite suppression for some patients